← Browse by Condition
Medical Condition
gastrointestinal neoplasms
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 1, Phase 2, Phase 2
ClinicalMetric tracks all active clinical trials for gastrointestinal neoplasms sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — gastrointestinal neoplasms Clinical Trials
How many clinical trials are currently recruiting for gastrointestinal neoplasms?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for gastrointestinal neoplasms, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for gastrointestinal neoplasms?
gastrointestinal neoplasms research spans Phase 1 (2 trials), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a gastrointestinal neoplasms clinical trial?
Eligibility criteria for gastrointestinal neoplasms trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 2
Top Sponsors
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06663319 Phase 1
Recruiting
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Enrollment
220 pts
Location
United States, South...
Sponsor
Janssen Research & Development...
NCT06885034 Phase 1, Phase 2
Recruiting
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
Enrollment
320 pts
Location
United States, Austr...
Sponsor
GlaxoSmithKline
NCT05494060 Phase 2
Recruiting
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
Enrollment
80 pts
Location
China
Sponsor
The First Affiliated Hospital ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology